Intrinsic Edge Capital Management LLC Castle Biosciences Inc Transaction History
Intrinsic Edge Capital Management LLC
- $1.24 Billion
- Q1 2024
A detailed history of Intrinsic Edge Capital Management LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 223,567 shares of CSTL stock, worth $4.87 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
223,567
Previous 326,270
31.48%
Holding current value
$4.87 Million
Previous $7.04 Million
29.66%
% of portfolio
0.4%
Previous 0.72%
Shares
13 transactions
Others Institutions Holding CSTL
# of Institutions
162Shares Held
25.3MCall Options Held
82.2KPut Options Held
150K-
Black Rock Inc. New York, NY2.6MShares$56.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.55MShares$55.5 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.63MShares$35.4 Million1.3% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.53MShares$33.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$32.5 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $572M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...